In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing the potential role of GLP-1 therapies in alcohol and substance use disorders, risk factors associated with long-term opioid prescribing, patient motivation and readiness to taper opioids for chronic pain, national trends in ADHD medication prescribing, and more!

• GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer Published in the Journal of Endocrine Society, October 2025
• A national cohort study of long-term opioid prescription and sociodemographic and health care-related risk factors Published in Communications Medicine, September 2025
• Patient Motivation to Reduce or Discontinue Opioids for Chronic Pain: Self-efficacy, Barriers, and Readiness to Change Published in the Clinical Journal of Pain, January 2024
• Population-Level Trends in Attention-Deficit/Hyperactivity Disorder Medication Prescribing Published in JAMA Network Open, December 2025
• Increased Avoidance Learning in Chronic Opioid Users Published in JAMA Pyschiatry, November 2025

In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing the relationship between medical cannabis and opioid receipt in chronic pain, clinical challenges in managing risks of continuing versus tapering long-term opioid therapy, the impact of cannabis use on nicotine vaping cessation outcomes, and more!

• Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain Published in JAMA Internal Medicine, December 2025
• Experiences of long-term benzodiazepine use and addiction amid changes in guidelines for the prescription of narcotic drugs: a qualitative study Published in Springer Nature Link, August 2025
• Management of patients at risk of harms from both continuing and discontinuing their long-term opioid therapy: A qualitative study to inform the gap in clinical practice guidelines Published in Pain Practice, January 2025
• Digital Cognitive Behavioral Treatment for Generalized Anxiety Disorder A Randomized Clinical Trial Published in JAMA Network Open, December 2025
• Cannabis Use and Nicotine Vaping Cessation Outcomes: A Secondary Analysis of a Randomized Clinical Trial Published in JAMA Network Open, December 2025

In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing healthcare enrollees and access outcomes, early high-risk opioid prescribing and persistent use among injured workers, the need for oversight of substance use reduction apps, barriers to universal MOUD availability in U.S. jails, and more!

• Trends in Methadone Use for Pain and Opioid Use Disorder Among Medicaid Enrollees Published in JAMA Health Forum, November 2025
• Early High-Risk Opioid Prescribing and Persistent Opioid Use in Australian Workers with Workers' Compensation Claims for Back and Neck Musculoskeletal Disorders or Injuries: A Retrospective Cohort Study Published in Springer Nature Link, March 2025
• The Need for Oversight Over Apps for Substance Use Reduction Published in JAMA, October 2025
• Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails Published in JAMA Network Open, April 2025
• Transient and Long-Term Risks of Common Physical Activities in People With Low Back Pain Published in JAMA Network Open, December 2025